Cover Image

Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda

Angela T Mlole, 1 James J Yahaya, 2 Emmanuel Othieno, 3 Sam Kalungi, 3 Andrew L Okwi 1 1Department of Pathology, Makerere College of Health Sciences (MaKCHS), Makerere University, Kampala, Uganda; 2Department of Biomedical Science, College of Health Science (CHS), The University of Dodoma, Dodoma, T...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mlole AT (Author), Yahaya JJ (Author), Othieno E (Author), Kalungi S (Author), Okwi AL (Author)
Format:	Book
Published:	Dove Medical Press, 2020-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
by: Kyu Sic You, et al.
Published: (2021)

The status of epidermal growth factor receptor and topoisomerase IIα genes in triple-negative breast cancer cells
by: D. A. Karseladze, et al.
Published: (2014)

The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
by: Eirini Kostopoulou, et al.
Published: (2018)

Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
by: Atif Ali Hashmi, et al.
Published: (2019)

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations
by: Nikolova Dafina, et al.
Published: (2022)

A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors
by: Mariane Teodoro Fernandes, et al.
Published: (2018)

Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids
by: Sepideh Mohammadhosseinpour, et al.
Published: (2024)

Association of Stress, Glucocorticoid Receptor, and FK506 Binding Protein Gene Polymorphisms With Internalizing Disorders Among HIV-Infected Children and Adolescents From Kampala and Masaka Districts-Uganda
by: Tonny Jimmy Owalla, et al.
Published: (2021)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017)

Modulation of Pathological Pain by Epidermal Growth Factor Receptor
by: Jazlyn P. Borges, et al.
Published: (2021)

Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer
by: Gamze Akoz, et al.
Published: (2018)

The role of epidermal growth factor-like module containing mucin-like hormone receptor 2 in human cancers
by: Michael Safaee, et al.
Published: (2014)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
by: ZiYan Yang, et al.
Published: (2021)

Transcriptional effects of inhibiting epidermal growth factor receptor in keratinocytes
by: Alix Gazel, et al.
Published: (2013)

Nuclear epidermal growth factor receptor as a therapeutic target
by: Benjamin Atwell, et al.
Published: (2023)

Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression
by: Yuquan Bai, et al.
Published: (2018)

High chromosomal instability is associated with higher 10‐year risks of recurrence for hormone receptor‐positive, human epidermal growth factor receptor 2‐negative breast cancer patients: clinical evidence from a large‐scale, multiple‐site, retrospective study
by: Yu‐Yang Liao, et al.
Published: (2024)

Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
by: Bahar Zehra Camurdanoglu Weber, et al.
Published: (2022)

The Relationship Between Fibroblastic Growth Factor Receptor-1 (FGFR1) Gene Amplification in Triple Negative Breast Carcinomas and Clinicopathological Prognostic Factors
by: Amir Hossein Jafarian, et al.
Published: (2019)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020)

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations
by: Lv Ning, et al.
Published: (2011)

Burden of tuberculosis in Kampala, Uganda
by: Guwatudde David, et al.
Published: (2003)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim, et al.
Published: (2021)

A validation study of human epidermal growth factor receptor 2 immunohistochemistry digital imaging analysis and its correlation with human epidermal growth factor receptor 2 fluorescence In situ hybridization results in breast carcinoma
by: Ramon Hartage, et al.
Published: (2020)

Immunohistochemical study of p53, Ki-67, epidermal growth factor receptor, and sex-determining region Y-box 2 in squamous cell carcinoma of tongue
by: Pallavi D Bhayekar, et al.
Published: (2016)

Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
by: Tomoko Hiraiwa, et al.
Published: (2018)

Idiopathic extensive acanthosis nigricans with a variant of the epidermal growth factor receptor
by: Amena Alkeswani, BS, et al.
Published: (2020)

Dermatological side effects of epidermal growth factor receptor inhibitors: 'Pride' complex
by: Bhushan Madke, et al.
Published: (2014)

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
by: Ashwaq Al Olayan, et al.
Published: (2012)

Desensitization by Different Strategies of Epidermal Growth Factor Receptor and ErbB4
by: Hideyuki Yamamoto, et al.
Published: (2014)

Immune responses to epidermal growth factor receptor (EGFR) and their application for cancer treatment
by: Tetsuro Sasada, et al.
Published: (2016)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
by: Naoyuki Nishiya, et al.
Published: (2019)

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression
by: Tatiana A. Slastnikova, et al.
Published: (2022)

Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations
by: Lamond NW, et al.
Published: (2014)

GABA Type A receptors expressed in triple negative breast cancer cells mediate chloride ion flux
by: J Bundy, et al.
Published: (2024)

A comparative analysis of body mass index with estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in pre- and postmenopausal breast cancer patients
by: Richa Chauhan, et al.
Published: (2020)

Expression of breast cancer type 1 and its relation with expression of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2/neu in breast carcinoma on trucut biopsy specimens
by: Deepti Verma, et al.
Published: (2018)

Analysis of the Clinical Molecular Characteristics and Neoadjuvant Chemotherapy Response in Patients with Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer and Axillary Lymph Node Metastasis
by: Jin-Ping Ma, et al.
Published: (2022)

Human immunodeficiency virus and AIDS and other important predictors of maternal mortality in Mulago Hospital Complex Kampala Uganda
by: Khainza Betty, et al.
Published: (2011)

Immunohistochemical staining of leptin is associated with grade, stage, lymph node involvement, recurrence, and hormone receptor phenotypes in breast cancer
by: Mohamad Nidal Khabaz, et al.
Published: (2017)